Contact this trialFirst, we need to learn more about you.
RNA Interference
AZD7503 for Non-alcoholic Fatty Liver Disease
Recruiting1 awardPhase 1
San Antonio, Texas
This trial is testing a new treatment for non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). A liver biopsy will be done to see if you qualify. If you do, you'll receive the treatment being studied.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.